Show simple item record

dc.contributor.authorMeehan, AC
dc.contributor.authorMifsud, NA
dc.contributor.authorNguyen, THO
dc.contributor.authorLevvey, BJ
dc.contributor.authorSnell, GI
dc.contributor.authorKotsimbos, TC
dc.contributor.authorWestall, GP
dc.date.accessioned2020-12-21T01:32:18Z
dc.date.available2020-12-21T01:32:18Z
dc.date.issued2013-03-21
dc.identifierpii: PONE-D-12-27918
dc.identifier.citationMeehan, A. C., Mifsud, N. A., Nguyen, T. H. O., Levvey, B. J., Snell, G. I., Kotsimbos, T. C. & Westall, G. P. (2013). Impact of Commonly Used Transplant Immunosuppressive Drugs on Human NK Cell Function Is Dependent upon Stimulation Condition. PLOS ONE, 8 (3), https://doi.org/10.1371/journal.pone.0060144.
dc.identifier.issn1932-6203
dc.identifier.urihttp://hdl.handle.net/11343/256552
dc.description.abstractLung transplantation is a recognised treatment for patients with end stage pulmonary disease. Transplant recipients receive life-long administration of immunosuppressive drugs that target T cell mediated graft rejection. However little is known of the impact on NK cells, which have the potential to be alloreactive in response to HLA-mismatched ligands on the lung allograft and in doing so, may impact negatively on allograft survival. NK cells from 20 healthy controls were assessed in response to Cyclosporine A, Mycophenolic acid (MPA; active form of Mycophenolate mofetil) and Prednisolone at a range of concentrations. The impact of these clinically used immunosuppressive drugs on cytotoxicity (measured by CD107a expression), IFN-γ production and CFSE proliferation was assessed in response to various stimuli including MHC class-I negative cell lines, IL-2/IL-12 cytokines and PMA/Ionomycin. Treatment with MPA and Prednisolone revealed significantly reduced CD107a expression in response to cell line stimulation. In comparison, addition of MPA and Cyclosporine A displayed reduced CD107a expression and IFN-γ production following PMA/Ionomycin stimulation. Diminished proliferation was observed in response to treatment with each drug. Additional functional inhibitors (LY294002, PD98059, Rottlerin, Rapamycin) were used to elucidate intracellular pathways of NK cell activation in response to stimulation with K562 or PMA-I. CD107a expression was significantly decreased with the addition of PD98059 following K562 stimulation. Similarly, CD107a expression significantly decreased following PMA-I stimulation with the addition of LY294002, PD98059 and Rottlerin. Ten lung transplant patients, not receiving immunosuppressive drugs pre-transplant, were assessed for longitudinal changes post-transplant in relation to the administration of immunosuppressive drugs. Individual patient dynamics revealed different longitudinal patterns of NK cell function post-transplantation. These results provide mechanistic insights into pathways of NK cell activation and show commonly administered transplant immunosuppression agents and clinical rejection/infection events have differential effects on NK cell function that may impact the immune response following lung transplantation.
dc.languageEnglish
dc.publisherPUBLIC LIBRARY SCIENCE
dc.titleImpact of Commonly Used Transplant Immunosuppressive Drugs on Human NK Cell Function Is Dependent upon Stimulation Condition
dc.typeJournal Article
dc.identifier.doi10.1371/journal.pone.0060144
melbourne.affiliation.departmentMicrobiology and Immunology
melbourne.source.titlePLoS One
melbourne.source.volume8
melbourne.source.issue3
dc.rights.licenseCC BY
melbourne.elementsid1223420
melbourne.contributor.authorNguyen, Thi Hoang Oanh
dc.identifier.eissn1932-6203
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record